France Active Pharmaceutical Ingredients Market Size & Outlook
France active pharmaceutical ingredients market, 2018-2030 (US$M)
Related Markets
France active pharmaceutical ingredients market highlights
- The France active pharmaceutical ingredients market generated a revenue of USD 4,327.6 million in 2023 and is expected to reach USD 6,033.2 million by 2030.
- The France market is expected to grow at a CAGR of 4.9% from 2024 to 2030.
- In terms of segment, synthetic was the largest revenue generating type of synthesis in 2023.
- Biotech is the most lucrative type of synthesis segment registering the fastest growth during the forecast period.
Active pharmaceutical ingredients market data book summary
| Market revenue in 2023 | USD 4,327.6 million |
| Market revenue in 2030 | USD 6,033.2 million |
| Growth rate | 4.9% (CAGR from 2023 to 2030) |
| Largest segment | Synthetic |
| Fastest growing segment | Biotech |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Synthetic, Biotech |
| Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
Other key industry trends
- In terms of revenue, France accounted for 1.8% of the global active pharmaceutical ingredients market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany active pharmaceutical ingredients market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 5,744.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Active Pharmaceutical Ingredients Market Scope
Active Pharmaceutical Ingredients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France active pharmaceutical ingredients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 69.86% in 2023. Horizon Databook has segmented the France active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of various companies producing small-scale APIs, such as Seqens CDMO, which provide custom HPAPI manufacturing, is expected to fuel market growth. The company opened a new manufacturing facility in September 2020.
Leading manufacturer Sanofi announced that it was planning to combine its manufacturing sites and create one API & product manufacturing site to fulfill in-house and other demands. It is estimated that the sales of this plant will cross EUR 1 billion by 2022.
In November 2022, MedinCell signed a loan agreement of USD 40 million with EIB for supporting development of innovative treatments. Furthermore, in October 2022, Merck KGaA expanded its production capacity in France for supporting production of mAbs.
Reasons to subscribe to France active pharmaceutical ingredients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France active pharmaceutical ingredients market databook
-
Our clientele includes a mix of active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into France active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France active pharmaceutical ingredients market size, by type of synthesis, 2018-2030 (US$M)
France Active Pharmaceutical Ingredients Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
